Albireo Pharma (ALBO) Prices 4M Share Common Offering at $40/Sh

Albireo Pharma Inc. (NASDAQ: ALBO) announced today the pricing of its previously announced underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $40.00 per share. Albireo’s gross proceeds from this offering are expected to be $160 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Albireo has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are being sold by Albireo. The offering is expected to close on or about September 14, 2020, subject to satisfaction of customary closing conditions.

Cowen and William Blair are acting as the joint book-running managers and representatives of the underwriters for the offering. Wedbush PacGrow, H.C. Wainwright & Co. and Baird are acting as co-managers for the offering.

You May Also Be Interested In

• Crescent Biopharma raises $143.7M in public offering on Nasdaq
• Alto Neuroscience prices $100M stock offering to fund depression trial
• DBV Technologies refreshes ATM program with $150M ADS offering